ホルマリン固定およびパラフィン包埋組織サンプルの質量分析イメージングを用いた腫瘍微小環境の理解を広げる

Executive Industry Relevance

Multiplexed mass spectrometry imaging of formalin-fixed, paraffin-embedded tissues enables high-plex spatial profiling of the tumor microenvironment, addressing a critical need in immuno-oncology discovery. This approach supports single-cell resolution and simultaneous quantification of up to 40 markers, providing predictive confidence for target validation and mechanistic de-risking. Integrating spatial and phenotypic data at this scale informs early portfolio triage and translational continuity in cancer R&D.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Enables interrogation of immune cell roles and spatial relationships within tumor tissues.
• Supports functional target validation by quantifying marker co-expression at single-cell resolution.
• Facilitates mechanistic de-risking through comprehensive immune landscape mapping.
• Provides predictive confidence for prioritizing immuno-oncology targets.

Screening & Assay Development

• Delivers validated, multiplexed antibody panels for robust tissue-based assays.
• Ensures reproducibility and quantitative outputs through standardized antibody optimization and validation.
• Prepares high-content imaging systems for scalable screening of tissue samples.
• Enables reliable evaluation of compound effects on immune cell phenotypes in situ.

Translational & Preclinical Research

• Aligns spatial biomarker analysis with disease-relevant tissue models.
• Maintains continuity from discovery through preclinical validation by preserving tissue architecture.
• Supports risk-adjusted advancement decisions based on comprehensive immune profiling.
• Facilitates translational biomarker discovery for immunotherapy development.

Pipeline & Workflow Integration

This imaging platform bridges early discovery, lead identification, and translational research by enabling high-plex, spatially resolved immune profiling in preserved tissue samples.

• Discovery Biology: Supports hypothesis testing and pathway clarification by mapping immune cell distributions and interactions.
• Screening: Provides assay readiness and reproducibility through validated multiplexed antibody panels.
• Analytics: Generates quantitative, spatially resolved data for robust statistical comparison of experimental conditions.
• Translational Research: Connects discovery findings to preclinical models via preserved tissue architecture and biomarker alignment.
• Enterprise Reuse: Establishes a reusable imaging and analysis capability for diverse oncology and immunology programs.

Operational & Enterprise Impact

• Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in immune target validation.
• Operational Value: Standardizes multiplexed imaging workflows for reproducibility and scalability.
• Strategic Value: Enables informed go/no-go decisions and capital-efficient portfolio management.
• Portfolio Impact: Supports risk-adjusted prioritization and advancement of immuno-oncology assets.

Implementation Considerations

• Requires expertise in antibody panel design, optimization, and validation for high-plex imaging.
• Demands access to secondary ion mass spectrometry imaging instrumentation and gold-coated slide preparation.
• Necessitates cross-team standardization of staining, imaging, and data processing protocols.
• Adaptation across tissue types and disease models may require panel re-optimization.
• Current limitations include reliance on third-party computational pathology software for advanced image analysis.

Biopharma FAQs